NCT03871010

Brief Summary

Integration of the Vascular Nursing Team of the Department of Haematooncology, University Hospital Ostrava for the needs of all clinical departments of the hospital. Assessment of local signs of inflammation in patients of the Department of Haematooncology and other clinical departments of the University Hospital Ostrava.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

October 6, 2020

Status Verified

October 1, 2020

Enrollment Period

3.2 years

First QC Date

March 10, 2019

Last Update Submit

October 5, 2020

Conditions

Keywords

Midline catheterVascular nursing team

Outcome Measures

Primary Outcomes (1)

  • Local signs of infection

    Local signs of infection were recorded, using the scoring system according to Madonna - see detailed description.

    3 days at minimum

Study Arms (3)

Neutropenia patients, Dept. of Haematooncology

Patients with neutropenia from the Department of Haematooncology were included in this group.

Device: Midline catheter

No neutropenia patients, Dept. of Haematooncology

Patients without neutropenia from the Department of Haematooncology were included in this group.

Device: Midline catheter

No neutropenia patients, other clinical depts.

Patients with neutropenia from the other clinical departments of the University Hospital Ostrava were included in this group.

Device: Midline catheter

Interventions

Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.

Neutropenia patients, Dept. of HaematooncologyNo neutropenia patients, Dept. of HaematooncologyNo neutropenia patients, other clinical depts.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Midline catheter hospitalized at clinical department of the University Hospital Ostrava, Czech Republic

You may qualify if:

  • insertion of Midline catheter by nurses from the Vascular Nursing Team
  • age over 18 years

You may not qualify if:

  • \- inability to insert the Midline catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava-Poruba, Czech Republic, 708 52, Czechia

Location

MeSH Terms

Conditions

InflammationInfections

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kateřina Hašová, Mgr.

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2019

First Posted

March 12, 2019

Study Start

February 1, 2017

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

October 6, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

The investigators have decided not to make individual participant data available to other researchers.

Locations